These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35689378)

  • 1. An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites.
    Pilon MO; Leclair G; Oussaïd E; St-Jean I; Jutras M; Gaulin MJ; Mongrain I; Busseuil D; Rouleau JL; Tardif JC; Dubé MP; de Denus S
    Clin Transl Sci; 2022 Aug; 15(8):2024-2034. PubMed ID: 35689378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
    Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.
    Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Merriman TR; Wright DFB; Drake J; Dalbeth N
    Clin Transl Sci; 2020 Jan; 13(1):110-115. PubMed ID: 31444839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.
    Roberts RL; Wallace MC; Phipps-Green AJ; Topless R; Drake JM; Tan P; Dalbeth N; Merriman TR; Stamp LK
    Pharmacogenomics J; 2017 Mar; 17(2):201-203. PubMed ID: 26810134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics.
    Vora B; Brackman DJ; Zou L; Garcia-Cremades M; Sirota M; Savic RM; Giacomini KM
    Clin Transl Sci; 2021 Jul; 14(4):1431-1443. PubMed ID: 33931953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.
    Wallace MC; Roberts RL; Nanavati P; Miner JN; Dalbeth N; Topless R; Merriman TR; Stamp LK
    Rheumatology (Oxford); 2018 Apr; 57(4):656-660. PubMed ID: 29342288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population.
    Zhang K; Li C
    Hereditas; 2019; 156():26. PubMed ID: 31367212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.
    Stamp LK; Wallace M; Roberts RL; Frampton C; Miner JN; Merriman TR; Dalbeth N
    Drug Metab Pharmacokinet; 2018 Dec; 33(6):241-242. PubMed ID: 30274827
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of benzbromarone on allopurinol/oxypurinol kinetics in patients with gout.
    Müller FO; Schall R; Groenewoud G; Hundt HK; van der Merwe JC; van Dyk M
    Eur J Clin Pharmacol; 1993; 44(1):69-72. PubMed ID: 8436158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol.
    Brackman DJ; Yee SW; Enogieru OJ; Shaffer C; Ranatunga D; Denny JC; Wei WQ; Kamatani Y; Kubo M; Roden DM; Jorgenson E; Giacomini KM
    Clin Pharmacol Ther; 2019 Sep; 106(3):623-631. PubMed ID: 30924126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of allopurinol riboside.
    Shapiro TA; Were JB; Danso K; Nelson DJ; Desjardins RE; Pamplin CL
    Clin Pharmacol Ther; 1991 May; 49(5):506-14. PubMed ID: 2029827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease.
    Kannangara DR; Roberts DM; Furlong TJ; Graham GG; Williams KM; Day RO
    Br J Clin Pharmacol; 2012 May; 73(5):828-9. PubMed ID: 22098112
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics.
    Hishe HZ; Stocker SL; Stamp LK; Dalbeth N; Merriman TR; Phipps-Green A; Wright DFB
    Clin Transl Sci; 2023 Mar; 16(3):422-428. PubMed ID: 36398357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort.
    Roman Y; Tiirikainen M; Prom-Wormley E
    Clin Rheumatol; 2020 Aug; 39(8):2387-2392. PubMed ID: 32107664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout.
    Kankam M; Hall J; Gillen M; Yang X; Shen Z; Lee C; Liu S; Miner JN; Walker S; Clauson V; Wilson D; Nguyen M
    J Clin Pharmacol; 2018 Sep; 58(9):1214-1222. PubMed ID: 29733447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Rheumatology (Oxford); 2012 Sep; 51(9):1670-6. PubMed ID: 22539486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.
    Stocker SL; Williams KM; McLachlan AJ; Graham GG; Day RO
    Clin Pharmacokinet; 2008; 47(2):111-8. PubMed ID: 18193917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
    Liu J; Yang W; Li Y; Wei Z; Dan X
    BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study.
    Zhang L; Spencer KL; Voruganti VS; Jorgensen NW; Fornage M; Best LG; Brown-Gentry KD; Cole SA; Crawford DC; Deelman E; Franceschini N; Gaffo AL; Glenn KR; Heiss G; Jenny NS; Kottgen A; Li Q; Liu K; Matise TC; North KE; Umans JG; Kao WH
    Am J Epidemiol; 2013 May; 177(9):923-32. PubMed ID: 23552988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.